⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16187233 | 0.67 | — | — | |
| SCHEMBL333354 | 0.67 | — | — | |
| SCHEMBL1326426 | 0.60 | — | — | |
| SCHEMBL20725138 | 0.59 | — | — | |
| SCHEMBL1905585 | 0.59 | — | — | |
| SCHEMBL21985140 | 0.55 | — | — | |
| SCHEMBL14390402 | 0.53 | — | — | |
| SCHEMBL8223214 | 0.53 | — | — | |
| SCHEMBL28852433 | 0.53 | — | — | |
| SCHEMBL1985536 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111344317-B | Iron tridentate carbene single-site catalysts | 埃克森美孚化学专利公司 | 2023-04-28 | — | — | CN | disclosed |
| EP-4043434-A1 | NOVEL SULFONYLIMINES | Karl-Franzens-Universität Graz (AT) | 2022-08-17 | — | — | EP | disclosed |
| WO-2022058745-A9 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022058745-A2 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2022-03-24 | — | — | WO | disclosed |
| CN-111344317-A | Iron tridentate carbene single site catalysts | 埃克森美孚化学专利公司 | 2020-06-26 | — | — | CN | disclosed |
| EP-3666757-A1 | PROCESS FOR PREPARING A PIPERIDIN-4-ONE | Karl-Franzens-Universität Graz (AT) | 2020-06-17 | — | — | EP | disclosed |
| WO-2020014269-A9 | BISPHOSPHONATE QUINOLONE CONJUGATES AND USES THEREOF | BIOVINC, LLC. (US) | 2020-03-05 | — | — | WO | disclosed |
| EP-1814884-A1 | PROCESS FOR PREPARING NOVEL CRYSTALLINE FORMS OF (2S)-1-[[(7R)-7-(3,4-DICHLOROPHENYL)-4,7-DIHYDRO-5-METHYLPYRAZOLO[1,5]PYRIMIDINE-6-YL]CARBONYL]-2-(4-FLUOROPHENYL) PYRROLIDINE, NOVEL STABLE FORMS PRODUCED THEREIN AND FORMULATIONS | Bristol-Myers Squibb Company (US) | 2007-08-08 | — | — | EP | disclosed |
| US-20060128726-A1 | Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations | BRISTOL-MYERS SQUIBB COMPANY | 2006-06-15 | — | — | US | disclosed |
| WO-2006057972-A1 | PROCESS FOR PREPARING NOVEL CRYSTALLINE FORMS OF (2S)-1-[[(7R)-7-(3,4-DICHLOROPHENYL)-4,7-DIHYDRO-5-METHYLPYRAZOLO[1,5]PYRIMIDINE-6-YL]CARBONYL]-2-(4-FLUOROPHENYL) PYRROLIDINE, NOVEL STABLE FORMS PRODUCED THEREIN AND FORMULATIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-06-01 | — | — | WO | disclosed |